242 results on '"Schwarz, Ute I"'
Search Results
2. Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada
3. Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation
4. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment
5. A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicity
6. Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
7. Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model.
8. Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model
9. Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada
10. Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations
11. Expression and localization of efflux drug transporters P-glycoprotein and breast cancer resistance protein (BCRP) in adult human pancreatic islet alpha and beta cells
12. Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis
13. Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care
14. Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
15. TPMT intermediate metabolizer status and thiopurine‐associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia
16. DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation
17. Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas
18. Targeted next generation sequencing as a tool for precision medicine
19. Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine‐Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia.
20. Arzneimittelinduzierte Symptome und Erkrankungen
21. Arzneimittelinformationsdienste für Ärzte
22. Arzneimittel-induzierte Symptome und Erkrankungen
23. Arzneimitteltherapieberatung für Ärzte
24. Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C
25. Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights
26. Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study
27. A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicity
28. In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)
29. Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates
30. Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy
31. A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
32. OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide
33. Genotype-Guided Dosing of Vitamin K Antagonists
34. OATP1B3 Is Expressed in Pancreatic β-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide
35. In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4).
36. Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events
37. Genetic determinants of response to warfarin during initial anticoagulation
38. Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response
39. Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis
40. Variant discovery using next-generation sequencing and its future role in pharmacogenetics
41. Genetics of Warfarin Response
42. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition
43. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants
44. Grapefruit juice ingestion significantly reduces talinolol bioavailability
45. Coordinate induction of both cytochrome P4503A and MDR1 by St Johnʼs wort in healthy subjects
46. Unwanted pregnancy on self-medication with St Johnʼs wort despite hormonal contraception
47. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine
48. Identification of functionally variant MDR1 alleles among European Americans and African Americans
49. Unexpected effect of verapamil on oral bioavailability of the β-blocker talinolol in humans
50. Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.